Molecular Partners AG
MOLN
$3.88
-$0.07-1.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -91.14% | -67.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -91.14% | -67.23% |
| Cost of Revenue | -10.97% | -13.04% | -16.26% | -13.35% | -8.28% |
| Gross Profit | 6.38% | 2.89% | 4.83% | -0.96% | -1.09% |
| SG&A Expenses | -3.98% | -7.43% | -7.07% | -3.96% | -4.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.95% | -11.45% | -13.72% | -10.78% | -7.32% |
| Operating Income | 5.66% | 4.28% | 5.51% | 0.56% | 0.78% |
| Income Before Tax | -7.02% | -20.57% | -0.05% | -15.74% | -1.61% |
| Income Tax Expenses | 4,900.00% | 21.74% | -- | -- | -- |
| Earnings from Continuing Operations | -7.03% | -20.57% | -0.05% | -15.74% | -1.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.03% | -20.57% | -0.05% | -15.74% | -1.61% |
| EBIT | 5.66% | 4.28% | 5.51% | 0.56% | 0.78% |
| EBITDA | 5.84% | 4.28% | 5.58% | 0.49% | 0.71% |
| EPS Basic | 0.42% | -9.43% | 11.10% | -5.80% | 4.15% |
| Normalized Basic EPS | 4.94% | -4.62% | 15.23% | -1.50% | 4.16% |
| EPS Diluted | 0.52% | -9.30% | 11.00% | -5.91% | 4.04% |
| Normalized Diluted EPS | 4.94% | -4.62% | 15.23% | -1.50% | 4.16% |
| Average Basic Shares Outstanding | 6.83% | 9.51% | 12.45% | 9.57% | 6.65% |
| Average Diluted Shares Outstanding | 6.83% | 9.51% | 12.45% | 9.57% | 6.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |